Producers Online
DRAPER, Utah, Sept. 26, 2024 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (Nasdaq: HQY) ("HealthEquity") today released research findings on how Health Savings Account (HSA) contribution strategies influence how employees participate in…
PLANO, Texas, Sept. 26, 2024 (GLOBE NEWSWIRE) -- Stryve Foods, Inc. (“Stryve” or “the Company”) (NASDAQ: SNAX), a pioneer in creating healthy and convenient protein snacks, announces the launch of…
Irvine, CA, Sept. 26, 2024 (GLOBE NEWSWIRE) -- Clean Energy Technologies, Inc. (“CETY”) (Nasdaq: CETY), a clean energy manufacturing and services company offering eco-friendly green energy solutions, clean energy fuels,…
Stolt-Nielsen Limited to Present the Results for the Third Quarter of 2024 LONDON, September 26, 2024 - Stolt-Nielsen Limited (Oslo Børs: SNI) will host a presentation to discuss the Company’s…
PRESS RELEASE Top rank for Wolters Kluwer in Newsweek’s survey on most trustworthy companies in the world Ranking recognizes “companies that have earned the confidence of consumers, investors and employees…
PORTMORE, Jamaica, Sept. 26, 2024 (GLOBE NEWSWIRE) -- ibex (NASDAQ: IBEX), a leading global provider of business process outsourcing (BPO) and customer engagement technology solutions, recently hosted its Back-To-School with…
BOCA RATON, Fla., Sept. 26, 2024 (GLOBE NEWSWIRE) -- Springbig, the leader in cannabis loyalty marketing and communications technology, is proud to announce its successful onboarding of GrowHealthy, one of…
CHICAGO, Sept. 26, 2024 (GLOBE NEWSWIRE) -- LKQ Corporation (Nasdaq: LKQ) will release its third quarter 2024 financial results on Thursday, October 24, 2024. Conference Call Details LKQ will host…
FORM 8.3– Amendment to 2. (a) (1) PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the…
Merger expands OncoC4’s wholly owned immunotherapy pipeline and establishes in-house clinical manufacturing capabilities Adds IND-ready AI-081, a PD-1/VEGF bispecific antibody with best-in-class potential and clinical-stage assets including next-generation siglec agonist…